Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Speech in ALS: Longitudinal Changes in Lips and Jaw Movements and Vowel Acoustics.

Yunusova Y, Green JR, Lindstrom MJ, Pattee GL, Zinman L.

J Med Speech Lang Pathol. 2013 Mar;21(1):1-13.

2.
3.

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole.

Corcia P, Gordon PH.

Ther Clin Risk Manag. 2012;8:359-66. doi: 10.2147/TCRM.S21981. Epub 2012 Aug 27.

4.

Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency.

Alavian KN, Dworetzky SI, Bonanni L, Zhang P, Sacchetti S, Mariggio MA, Onofrj M, Thomas A, Li H, Mangold JE, Signore AP, Demarco U, Demady DR, Nabili P, Lazrove E, Smith PJ, Gribkoff VK, Jonas EA.

Brain Res. 2012 Mar 29;1446:1-11. doi: 10.1016/j.brainres.2012.01.046. Epub 2012 Jan 28.

5.

The abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: the importance of free oxygen radicals and mitochondrial integrity.

Boscolo A, Starr JA, Sanchez V, Lunardi N, DiGruccio MR, Ori C, Erisir A, Trimmer P, Bennett J, Jevtovic-Todorovic V.

Neurobiol Dis. 2012 Mar;45(3):1031-41. doi: 10.1016/j.nbd.2011.12.022. Epub 2011 Dec 14.

7.

Current and emerging treatments for amyotrophic lateral sclerosis.

Zoccolella S, Santamato A, Lamberti P.

Neuropsychiatr Dis Treat. 2009;5:577-95. Epub 2009 Nov 16.

8.

Catalytic antioxidants and neurodegeneration.

Golden TR, Patel M.

Antioxid Redox Signal. 2009 Mar;11(3):555-70. doi: 10.1089/ARS.2008.2256. Review.

Items per page

Supplemental Content

Write to the Help Desk